Five ITP and five control whole blood samples were collected with IRB approval. The age range of ITP patients was 1-54 years, and the range in platelet counts was 2,000-98,000 W 109/L. We examined onl
CD69 and CD25 expressions within the CD3+CD8+ population of hu-PBMCs co-grafted with MDA-MB-231 cells in embryos treated either with NaCl or with pembrolizumab.